BSO-induced reduction of glutathione levels increases the cellular radiosensitivity of drug-resistant human tumor cells.
Acquired resistance to cis-platinum and melphalan, in the human ovarian OAW42 tumor cell line, respectively, conferred a 3- and 1.5-fold decrease in photon sensitivity. Analysis of cell survival curves by the linear quadratic equation showed an accompanying 5- and 2-fold reduction in the magnitude of the initial slope (alpha). Treatment with the GSH depleting agent BSO restored the magnitude of alpha to a value similar to that of the parental line without evidence of dose modification in the high-dose region of the cell survival curve. This in conjunction with failure of alteration in GSH levels to affect parental OAW2 sensitivity and of the SER of BSO to reflect GSH levels suggest a possible GSH independent mechanism of action for BSO. If similar patterns occur in the clinic, the possibility exists of circumventing collateral resistance between chemotherapeutic agents and ionizing radiation, provided that tumor thiol levels can be preferentially depleted.
Britten
R A
RA
Department of Medicine, University of Liverpool, UK.
Warenius
H M
HM
White
R
R
Peacock
J
J
D019328:Buthionine Sulfoximine; D003864:Depression, Chemical; D004351:Drug Resistance; D005260:Female; D005978:Glutathione / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D008717:Methionine Sulfoximine / Q000031:analogs & derivatives* / Q000494:pharmacology; D011836:Radiation Tolerance / Q000502:physiology*; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000528:radiation effects
D008717:Methionine Sulfoximine; D019328:Buthionine Sulfoximine; D005978:Glutathione